Cargando…

Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors

Bitter taste receptors (T2Rs) are expressed in several tissues of the body and are involved in a variety of roles apart from bitter taste perception. Advanced glycation end-products (AGEs) are produced by glycation of amino acids in proteins. There are varying sources of AGEs, including dietary food...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaggupilli, Appalaraju, Howard, Ryan, Aluko, Rotimi E., Chelikani, Prashen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628017/
https://www.ncbi.nlm.nih.gov/pubmed/31212814
http://dx.doi.org/10.3390/nu11061317
_version_ 1783434867770392576
author Jaggupilli, Appalaraju
Howard, Ryan
Aluko, Rotimi E.
Chelikani, Prashen
author_facet Jaggupilli, Appalaraju
Howard, Ryan
Aluko, Rotimi E.
Chelikani, Prashen
author_sort Jaggupilli, Appalaraju
collection PubMed
description Bitter taste receptors (T2Rs) are expressed in several tissues of the body and are involved in a variety of roles apart from bitter taste perception. Advanced glycation end-products (AGEs) are produced by glycation of amino acids in proteins. There are varying sources of AGEs, including dietary food products, as well as endogenous reactions within our body. Whether these AGEs are T2R ligands remains to be characterized. In this study, we selected two AGEs, namely, glyoxal-derived lysine dimer (GOLD) and carboxymethyllysine (CML), based on their predicted interaction with the well-studied T2R4, and its physiochemical properties. Results showed predicted binding affinities (K(d)) for GOLD and CML towards T2R4 in the nM and μM range, respectively. Calcium mobilization assays showed that GOLD inhibited quinine activation of T2R4 with IC(50) 10.52 ± 4.7 μM, whilst CML was less effective with IC(50) 32.62 ± 9.5 μM. To characterize whether this antagonism was specific to quinine activated T2R4 or applicable to other T2Rs, we selected T2R14 and T2R20, which are expressed at significant levels in different human tissues. A similar effect of GOLD was observed with T2R14; and in contrast, GOLD and CML activated T2R20 with an EC(50) of 79.35 ± 29.16 μM and 65.31 ± 17.79 μM, respectively. In this study, we identified AGEs as novel T2R ligands that caused either activation or inhibition of different T2Rs.
format Online
Article
Text
id pubmed-6628017
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66280172019-07-23 Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors Jaggupilli, Appalaraju Howard, Ryan Aluko, Rotimi E. Chelikani, Prashen Nutrients Article Bitter taste receptors (T2Rs) are expressed in several tissues of the body and are involved in a variety of roles apart from bitter taste perception. Advanced glycation end-products (AGEs) are produced by glycation of amino acids in proteins. There are varying sources of AGEs, including dietary food products, as well as endogenous reactions within our body. Whether these AGEs are T2R ligands remains to be characterized. In this study, we selected two AGEs, namely, glyoxal-derived lysine dimer (GOLD) and carboxymethyllysine (CML), based on their predicted interaction with the well-studied T2R4, and its physiochemical properties. Results showed predicted binding affinities (K(d)) for GOLD and CML towards T2R4 in the nM and μM range, respectively. Calcium mobilization assays showed that GOLD inhibited quinine activation of T2R4 with IC(50) 10.52 ± 4.7 μM, whilst CML was less effective with IC(50) 32.62 ± 9.5 μM. To characterize whether this antagonism was specific to quinine activated T2R4 or applicable to other T2Rs, we selected T2R14 and T2R20, which are expressed at significant levels in different human tissues. A similar effect of GOLD was observed with T2R14; and in contrast, GOLD and CML activated T2R20 with an EC(50) of 79.35 ± 29.16 μM and 65.31 ± 17.79 μM, respectively. In this study, we identified AGEs as novel T2R ligands that caused either activation or inhibition of different T2Rs. MDPI 2019-06-12 /pmc/articles/PMC6628017/ /pubmed/31212814 http://dx.doi.org/10.3390/nu11061317 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jaggupilli, Appalaraju
Howard, Ryan
Aluko, Rotimi E.
Chelikani, Prashen
Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors
title Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors
title_full Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors
title_fullStr Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors
title_full_unstemmed Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors
title_short Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors
title_sort advanced glycation end-products can activate or block bitter taste receptors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628017/
https://www.ncbi.nlm.nih.gov/pubmed/31212814
http://dx.doi.org/10.3390/nu11061317
work_keys_str_mv AT jaggupilliappalaraju advancedglycationendproductscanactivateorblockbittertastereceptors
AT howardryan advancedglycationendproductscanactivateorblockbittertastereceptors
AT alukorotimie advancedglycationendproductscanactivateorblockbittertastereceptors
AT chelikaniprashen advancedglycationendproductscanactivateorblockbittertastereceptors